The 6 analysts offering 12-month price forecasts for Zealand Pharma A/S have a median target of 38.82, with a high estimate of 48.34 and a low estimate of 28.47. The median estimate represents a +76.47% increase from the last price of 22.00.
The current consensus among 6 polled investment analysts is to Buy stock in Zealand Pharma A/S. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.97
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.